POONGJEON PHARMACY (298060)

KOSDAQ · 2,450 KRW · As of Aug 26, 2026 close

1Y Close · As of Aug 26, 2026

Mkt Cap

23.6B

Rev (2025)

23.8B

Op Inc (2025)

-4.5B

Net Inc (2025)

203M

PBR

0.65

52W

0K~3K

POONGJEON PHARMACY operates in the Pharmaceuticals sector.

Legal name: POONGJEON PHARMACY CO.,LTD.

In fiscal year 2025, POONGJEON PHARMACY (298060) reported revenue of 23.8 billion KRW, up 2790.3% from 825 million KRW a year earlier.

Operating profit was -4.5 billion KRW and net income was 203 million KRW in the same year.

As of the Aug 26, 2026 close, the market capitalization was 23.6 billion KRW, with a P/B of 0.65.

These figures can be verified in the DART filing (receipt no. 20260316001672).

Year	Rev	Op Inc	Net Inc
2025	23.8B	-4.5B	203M
2024	825M	-11.3B	-12.4B

4 applicable out of 8 items

Semi-Annual Report (2026.06)

전환가액의조정 (제2회차)

Checks

4 of 8 checked items currently applicable.

Market Cap & Price: Market cap is above the delisting threshold.

Administrative Designation: 2 administrative designation criteria met. [source]

Audit Opinion: Audit opinion: Unqualified (clean).

Convertible Bonds: Convertible bonds outstanding with 0.06% potential dilution.

Capital Increase: 1 capital-increase filing(s) in the last 180 days. [source]

Treasury Stock: No treasury stock filings.

Embezzlement & Litigation: No embezzlement or litigation filings in the last 180 days.

Major Shareholder Change: No major shareholder changes in the last 180 days.

Market Action: 2 market action(s) (trading halt, delisting, etc.) recorded. [source]

These checks are mechanical tests of disclosed figures and do not constitute investment advice or recommendations.

Date	Filing
2026-08-14	Semi-Annual Report (2026.06)
2026-08-04	전환가액의조정 (제2회차)